SCHEMBL4318709

SCHEMBL4318709

CCC[C@@H](C(N)=O)N(CCCc1ccc(OC[C@@H](O)CO)cc1)C(=N)N

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 3/20 0.43
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SCNN1A P37088 3/20 0.39
S1PR4 O95977 2/20 0.38
S1PR5 Q9H228 2/20 0.38
S1PR2 O95136 1/20 0.38
S1PR3 Q99500 1/20 0.38
PLA2G4B P0C869 1/20 0.37
ABCB1 P08183 2/20 0.37
LMNA P02545 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
CNR1 P21554 1/20 0.36
ADRA1D P25100 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4318130 0.99 S1PR1 (0.42) S1PR1ALDH1A1CYP1A2CYP2D6MAPT
SCHEMBL4313541 0.84 ALOX5 (0.43) ALDH1A1
SCHEMBL4324683 0.84 ALOX5 (0.43) ALDH1A1
Hydrochloric Acid SCHEMBL4323499 0.83 ALOX5 (0.42) ALDH1A1
Trifluoroacetic Acid SCHEMBL4315300 0.81 KDM4E (0.42) ALDH1A1TDP1
SCHEMBL4318718 0.74 S1PR1 (0.41) S1PR1CYP1A2SCNN1AABCB1LMNA
Hydrochloric Acid SCHEMBL1134509 0.74 SCNN1A (0.56) SCNN1A
SCHEMBL12087447 0.74 SCNN1A (0.50) S1PR1SCNN1A
SCHEMBL11980604 0.74 S1PR1 (0.58) S1PR1ALDH1A1CYP2D6S1PR4S1PR5
SCHEMBL1586552 0.73 S1PR1 (0.50) S1PR1CYP2D6S1PR4S1PR5S1PR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP claimed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO claimed
US-8664228-B2 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of airway diseases NOVARTIS AG (CH) 2014-03-04 US disclosed
EP-2285785-B1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2012-09-05 EP disclosed
WO-2009138378-A1 3,5-DIAMINO-6-CHLORO-PYRAZINE-2-CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS EPITHELIAL SODIUM CHANNEL BLOCKERS FOR THE TREATMENT OF ARWAY DISEASES NOVARTIS AG (CH) 2009-11-19 WO disclosed